Global patient monitoring markets projected to grow through 2031

The global markets for remote patient monitoring (RPM) and patient monitoring devices are projected to see significant growth through 2031. The RPM market is expected to rise from USD 36.29 billion in 2026 to USD 66.33 billion by 2031, representing a compound annual growth rate (CAGR) of 12.8%. Meanwhile, the broader patient monitoring devices market is forecasted to grow from USD 55.60 billion in 2026 to USD 76.11 billion by 2031, with a CAGR of 6.4%.

Key drivers for this expansion include an aging global population and the increasing prevalence of chronic conditions such as diabetes, hypertension, and cardiovascular diseases. The shift toward connected healthcare, driven by advancements in wearable technology, AI-powered analytics, and wireless connectivity, is facilitating more proactive disease management and reducing the need for frequent hospital visits.

In the RPM sector, the device segment—including wearables, implantable technologies, and handheld devices—holds a significant market share. Within the broader monitoring market, hospitals and clinics remain the largest end-user segment, while blood glucose monitoring devices represent a leading product segment.